…
Convergence Healthcare Advisors served as exclusive strategic advisor to Natera, Inc. on the sale of the Evercord business to CBR.
LOS ANGELES, Sept. 13, 2019 /PRNewswire/ — CBR (Cord Blood Registry), the world’s largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.’s (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually beneficial move brings together two of the industry’s most respected newborn stem cell storage companies. “As a pillar of the California Cryobank Life Sciences (CCLS) organization, CBR is built on scientific excellence, leadership, and best-in-class services,” said Richard Jennings, California Cryobank Life Sciences, CEO. …
Seven Hills Healthcare Advisors represents HEALTHGRID in sale to ALLSCRIPTS HEALTHCARE SOLUTIONS
Seven Hills Healthcare Advisors represents HEALTHGRID in sale to ALLSCRIPTS HEALTHCARE SOLUTIONS May 3, 2018 Seven Hills Healthcare Advisors* is pleased to announce our role as exclusive strategic advisor to Health Grid Holding Company in its sale to Allscripts Healthcare Solutions. Terms of the transaction were not disclosed. HealthGrid is a leader in the rapidly evolving healthcare patient engagement sector. Industry analyst KLAS defines patient engagement as “the process of motivating and enabling patients to participate in their own care with the expectation that, over time, …
Convergence Healthcare advises Dynex Technologies in its sale to Telegraph Hill Partners
Dynex Technologies (Dynex) has been acquired by Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated to the life science and healthcare industries. THP will infuse Dynex with significant resources and capital, enabling the company to expand its operations, improve manufacturing capacity and grow its client services organization. “We are proud of our 60-year history of delivering best in class products with an ongoing commitment to innovation. With THP’s additional resources, we look forward to continuing to execute on our strategy for future growth,” …
Convergence Healthcare advises Magellan Diagnostics in its sale to Meridian Biosciences for $66 million
Meridian Bioscience, Inc., Cincinnati, Ohio (VIVO) announced today that it has completed the acquisition of Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. Headquartered in Billerica, Massachusetts (near Boston), Magellan pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. Today, Magellan is the leading provider of point-of-care lead testing systems with placements in more than 6,500 physician offices and clinics nationwide. Its position in pediatric …